CRLComplete Response Letter
Complete Response Letter United Therapeutics Corporation (Oct 7, 2016)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Device constituent and human factors. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• REMODULIN
